Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients

Dave E. W. van der Kruijssen, Karlijn L. van Rooijen, Sophie A. Kurk, Johannes H. W. de Wilt, Cornelis J. A. Punt, Geraldine R. Vink, Sjoerd G. Elias, Miriam Koopman

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

Introduction: Uncertainty exists about a possible survival benefit of primary tumor resection (PTR) in synchronous metastatic colon cancer (mCC). Since sidedness of the primary tumor is regarded as an important prognostic factor, our objective was to study the interaction between PTR and sidedness in synchronous mCC. Methods: In this retrospective study, we used data from 2 first-line phase 3 randomized controlled trials (RCTs). A mixed Cox regression model was used to study the multiplicative interaction between PTR and sidedness. We adjusted for age, treatment arm, WHO performance status, number of affected organs by metastases, serum lactate dehydrogenase, and year of enrollment. Results: We found that PTR is associated with better survival in both right-sided (hazard ratio [HR] 0.59 [95% confidence interval 0.42-0.8 2]) and left-sided mCC (HR 0.70 [95% confidence interval 0.52-0.93]). The interaction between PTR and sidedness was not significant (p = 0.45). Conclusion: Our data suggest that the prognostic value of PTR is independent of sidedness. Validation of these results will be performed in ongoing RCTs.
Original languageEnglish
Pages (from-to)283-289
Number of pages7
JournalDigestive Surgery
Volume38
Issue number4
Early online date2021
DOIs
Publication statusPublished - 1 Sept 2021

Keywords

  • Metastatic colon cancer
  • Primary tumor resection
  • Sidedness
  • Systemic therapy

Cite this